Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 10,763,800 | 9,703,300 | 6,932,200 | 5,516,461 | 5,048,634 |
| Cost of Goods | 1,240,400 | 1,171,000 | 857,700 | 545,494 | 466,780 |
| Gross Profit | 9,523,399 | 8,532,300 | 6,074,500 | 4,970,967 | 4,581,854 |
| Operating Expenses | 4,632,800 | 4,559,800 | 3,559,800 | 3,115,612 | 2,857,943 |
| Operating Income | 4,891,000 | 3,972,400 | 2,515,500 | 1,855,849 | 1,724,691 |
| Other Income | -136,200 | -40,900 | -52,100 | -5,262 | -13,477 |
| Pre-tax Income | 4,754,800 | 3,931,500 | 2,463,400 | 1,850,587 | 1,711,214 |
| Income Tax | 1,161,600 | 989,900 | 601,000 | 470,554 | 444,528 |
| Net Income Continuous | 3,593,200 | 2,941,600 | 1,862,400 | 1,380,033 | 1,266,686 |
| Minority Interests | 46,200 | 6,800 | N/A | N/A | 32,258 |
| Net Income | $3,547,000 | $2,934,800 | $1,862,300 | $1,380,033 | $1,234,428 |
| EPS Basic Total Ops | 15.38 | 12.42 | 7.86 | 5.80 | 5.09 |
| EPS Basic Continuous Ops | 15.58 | 12.44 | 7.86 | 5.80 | 5.23 |
| EPS Diluted Total Ops | 15.34 | 12.37 | 7.81 | 5.76 | 5.04 |
| EPS Diluted Continuous Ops | 15.54 | 12.40 | 7.82 | 5.76 | 5.17 |
| EBITDA(a) | $5,491,399 | $4,660,600 | $3,047,100 | $2,221,497 | $2,083,624 |